CCIA
IPXL

Campbell & Co Investment Adviser’s Impax Laboratories, Inc. IPXL Stock Holding History

Campbell & Co Investment Adviser’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-18,732
Closed -$383K – 351
2013
Q3 		$383K Buy
+18,732
New +$387K 0.08% 186

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Campbell & Co Investment Adviser's IPXL Position: Q4 2013 in Review

Campbell & Co Investment Adviser sold out of Impax Laboratories, Inc. (IPXL) in Q4 2013, closing a stake of 18,732 shares — an estimated $383K sold.

Campbell & Co Investment Adviser first reported a position in IPXL in Q3 2013 and held it in 1 quarter. The position peaked at $383K in Q3 2013. 166 funds tracked by Wall St. Rank hold IPXL as of Q4 2013.

  • Campbell & Co Investment Adviser reported no remaining Impax Laboratories, Inc. position as of Q4 2013 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 18,732 Impax Laboratories, Inc. shares in Q4 2013, an estimated $383K.
  • Campbell & Co Investment Adviser first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Impax Laboratories, Inc. position peaked at $383K in Q3 2013.
  • 166 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2013.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2013, filed 6 Feb 2014.